Christophe Richez

10.3k citations
148 papers · 4.6k indexed · 2 hit papers · h-index 37
Topics
Systemic Lupus Erythematosus Research (61 papers)Rheumatoid Arthritis Research and Therapies (35 papers)Monoclonal and Polyclonal Antibodies Research (19 papers)
Partner nations
FranceUnited StatesSpain

In The Last Decade

Christophe Richez

139 papers receiving 4.5k citations

Hit Papers

Trial of Anifrolumab in Active Systemic Lupus Erythematosus201920262021202320192023250500750

Peers

Christophe Richez
Comparison fields: 5 of 117
  • Rheumatology 2.4k
  • Immunology 2.2k
  • Oncology 737
  • Molecular Biology 618
  • Hematology 560
Replace Alexis Mathian with:
Alexis Mathian France
Amr H. Sawalha United States
Prodromos Sidiropoulos Greece
Jacques‐Eric Gottenberg France
Eugen Feist Germany
W. Joseph McCune United States
Carlos Abud‐Mendoza Mexico
Diego Kyburz Switzerland
Mario García‐Carrasco Mexico
Dae‐Hyun Yoo South Korea
Christophe Richez relative to Alexis Mathian France Alexis Mathian's profile →
Citations per field
00.5×1.6×
Alexis Mathian · 1×
Citations per year

Countries citing papers authored by Christophe Richez

Since Specialization
Citations

This map shows the geographic impact of Christophe Richez's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christophe Richez with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christophe Richez more than expected).

Fields of papers citing papers by Christophe Richez

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christophe Richez. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christophe Richez. The network helps show where Christophe Richez may publish in the future.

Co-authorship network of co-authors of Christophe Richez

This figure shows the co-authorship network connecting the top 25 collaborators of Christophe Richez. A scholar is included among the top collaborators of Christophe Richez based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christophe Richez. Christophe Richez is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 6
3 0
4 10
5 2
6 14
7 2
8 6
9 67
10 19
11 1
12 62
13 6
14 61
15 37
16 38
17 79
18 93
19 74
20 51

About Christophe Richez

Christophe Richez is a scholar working on Rheumatology, Immunology and Hematology, having authored 148 papers that have together received 4.6k indexed citations. Recurring topics across this work include Systemic Lupus Erythematosus Research (61 papers), Rheumatoid Arthritis Research and Therapies (35 papers) and Monoclonal and Polyclonal Antibodies Research (19 papers). The work is most often cited by research in Rheumatology (2.4k citations), Immunology (2.2k citations) and Hematology (560 citations). Christophe Richez has collaborated with scholars based in France, United States and Spain. Frequent co-authors include Patrick Blanco, Thierry Schaeverbeke, Marie‐Elise Truchetet, Estibaliz Lazaro, P. Duffau, Thomas Barnetche, Ian R. Rifkin, Ian N Bruce, Eric F. Morand and Philip Z. Brohawn. Their work appears in journals such as New England Journal of Medicine, Nature Communications and Nature reviews. Immunology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026